Position in HLN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,455,674
-$1,265,063 QoQ
Shares Held
263,202
-29.2% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#100
of 640 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 9%
Shared 0%
None 91%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $43,412,538 across 29 Drug Manufacturers - Specialty & Generic names. HLN ranks #5 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
121,151 | $8,705,910 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
45,360 | $7,644,974 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
9,855 | $5,339,734 | |
| 4 | VTRS |
Viatris Inc
|
197,717 | $3,139,745 | |
| 5 | HLN |
Haleon plc
This page
|
263,202 | $2,455,674 | |
| 6 | HROW |
Harrow, Inc.
|
56,414 | $2,395,902 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
143,998 | $2,308,287 | |
| 8 | ALKS |
Alkermes plc.
|
42,278 | $2,215,367 |
All Filings in HLN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,455,674 | 263,202 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,720,737 | 371,702 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,338,079 | 330,176 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,184,168 | 243,497 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $2,789,903 | 269,036 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $2,743,931 | 266,660 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,832,931 | 296,953 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,199,000 | 302,363 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,574,385 | 311,669 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $2,252,923 | 265,362 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,835,341 | 344,513 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,417,624 | 290,231 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $755,834 | 90,195 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $797,190 | 97,935 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $585,928 | 73,241 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $448,491 | 73,644 | Shares | Sole | 2022-11-16 | |
| No filing history on record for this holder in this stock. | ||||||